International Research Journal of Engineering and Technology (IRJET)
e-ISSN: 2395-0056
Volume: 12 Issue: 04 | Apr 2025
p-ISSN: 2395-0072
www.irjet.net
"Emerging Biotechnological Advances and Their Influence on Personalized Medicine" Princy Ashishkumar Modi 1 Princy Ashishkumar Modi Surat, India Independent Researcher | princymodi0115@gmail.com ---------------------------------------------------------------------***---------------------------------------------------------------------
Abstract
making (Mardis, 2017). Moreover, CRISPR-Cas9 and other gene-editing tools have opened new avenues for therapeutic interventions by correcting disease-causing mutations at the genomic level (Barrangou & Doudna, 2016).
Personalized medicine represents a transformative shift in healthcare, offering tailored treatments based on an individual's genetic, environmental, and lifestyle factors. At the heart of this medical revolution are emerging biotechnological advances that are reshaping how diseases are diagnosed, monitored, and treated. This review explores the latest innovations in biotechnology—including next-generation sequencing, CRISPR gene editing, biomarker discovery, pharmacogenomics, and bioinformatics—and their pivotal roles in advancing personalized medicine. The integration of these technologies has enabled more accurate disease prediction, real-time patient monitoring, and customized therapeutic strategies, significantly improving clinical outcomes. Furthermore, the synergistic impact of artificial intelligence and big data analytics is enhancing the precision and efficiency of biotechnological applications. While the potential of these innovations is vast, challenges such as ethical concerns, data privacy, cost, and accessibility continue to be important considerations for the broader implementation of personalized medicine.
Additionally, the integration of artificial intelligence (AI) and machine learning into biotechnology has enhanced the predictive power of diagnostic tools and treatment algorithms. These technologies analyze vast datasets to identify molecular patterns, predict disease progression, and optimize drug development (Topol, 2019). Liquid biopsy, another emerging innovation, allows for the non-invasive detection of circulating tumor DNA and other biomarkers, facilitating early diagnosis and real-time monitoring of disease (Wan et al., 2017).
Key Words:
Personalized Medicine, Biotechnology, Genomics, CRISPR, Pharmacogenomics, Biomarkers, Bioinformatics.
1.INTRODUCTION In recent decades, biotechnology has undergone rapid and transformative advancements, significantly impacting the landscape of personalized medicine. Personalized medicine also referred to as precision medicine entails tailoring medical treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors. This shift from a "one-size-fits-all" approach to individualized healthcare is largely driven by technological breakthroughs in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics (Collins & Varmus, 2015).
Fig -1: Biotechnological tools The convergence of these biotechnological innovations is not only reshaping clinical practices but also redefining the ethical, regulatory, and economic frameworks of modern medicine. As precision medicine becomes more embedded in healthcare systems worldwide, it holds the promise of improving patient outcomes, minimizing adverse drug reactions, and enhancing the overall efficiency of medical interventions.
One of the cornerstones of personalized medicine is the availability of high-throughput sequencing technologies such as next-generation sequencing (NGS), which have made whole genome and exome sequencing faster and more costeffective. These advancements enable the identification of genetic mutations, disease susceptibilities, and pharmacogenomic profiles that guide clinical decision-
© 2025, IRJET
|
Impact Factor value: 8.315
Despite these promising developments, challenges such as data privacy concerns, equitable access, and integration into
|
ISO 9001:2008 Certified Journal
|
Page 994